Literature DB >> 25707055

Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia.

Lucy T Xu, Robert J Courtney, Justis P Ehlers.   

Abstract

Waldenström's macroglobulinemia (WM) is associated with retinal findings of hyperviscosity, such as venous dilation, and findings of immunogammopathy maculopathy, such as serous macular detachment. This report describes a case of bilateral serous macular detachment with intraretinal schisis-like fluid in a patient with WM. Enhanced depth imaging optical coherence tomography revealed a thickened choroid with hyperreflective accumulations in the retinal pigment epithelium layer. Ultrawide-field fundus autofluorescence demonstrated a central area of hyperautofluorescence corresponding to the area of serous macular detachment. Ultrawide-field fluorescein angiography was characteristically silent. Intravitreal bevacizumab therapy resulted in significant reduction in intraretinal fluid but minimal change in subretinal fluid. Long-term follow-up demonstrated alterations in retinal architecture and improved serous detachments. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25707055      PMCID: PMC4455023          DOI: 10.3928/23258160-20150213-06

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  12 in total

1.  Unusual immunogammopathy maculopathy.

Authors:  A C Ho; W E Benson; J Wong
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

2.  Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.

Authors:  Andrew F Pilon; Paul S Rhee; Leonard V Messner
Journal:  Optom Vis Sci       Date:  2005-07       Impact factor: 1.973

3.  IgM paraprotein in the subretinal fluid of a patient with recurrent retinal detachment and Waldenström's macroglobulinaemia.

Authors:  A Berta; P Beck; J Mikita
Journal:  Acta Med Hung       Date:  1985

4.  Immunofluorescent studies of the eye in Waldenström's macroglobulinemia.

Authors:  A H Freidman; A Marchevsky; J G Odel; M A Gerber; S N Thung
Journal:  Arch Ophthalmol       Date:  1980-04

5.  Waldenström macroglobulinemia.

Authors:  Morie A Gertz
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

6.  Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema.

Authors:  Cagri G Besirli; Mark W Johnson
Journal:  Retin Cases Brief Rep       Date:  2013

7.  Immunogammopathies and acquired vitelliform detachments: a report of four cases.

Authors:  Irene M Rusu; Sarah Mrejen; Michael Engelbert; Roberto Gallego-Pinazo; Michael D Ober; Mark W Johnson; Anita Leys; Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2013-12-07       Impact factor: 5.258

8.  Serous macular detachment in Waldenström macroglobulinemia: a report of four cases.

Authors:  Paul S Baker; Sunir J Garg; Mitchell S Fineman; Allen Chiang; Rayan A Alshareef; Jonathan Belmont; Gary C Brown
Journal:  Am J Ophthalmol       Date:  2012-12-04       Impact factor: 5.258

9.  Ocular pathology in light chain deposition disease.

Authors:  B C Daicker; M J Mihatsch; E H Strøm; G B Fogazzi
Journal:  Eur J Ophthalmol       Date:  1995 Apr-Jun       Impact factor: 1.922

10.  Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease.

Authors:  Vito Fenicia; Marco Balestrieri; Andrea Perdicchi; Giorgia Maraone; Santi Maria Recupero
Journal:  Case Rep Ophthalmol       Date:  2013-07-26
View more
  6 in total

1.  Regulation of Adrenergic, Serotonin, and Dopamine Receptors to Inhibit Diabetic Retinopathy: Monotherapies versus Combination Therapies.

Authors:  Timothy S Kern; Yunpeng Du; Jie Tang; Chieh Allen Lee; Haitao Liu; Alyssa Dreffs; Henri Leinonen; David A Antonetti; Krzysztof Palczewski
Journal:  Mol Pharmacol       Date:  2021-08-15       Impact factor: 4.054

2.  Multimodal imaging in immunogammopathy maculopathy secondary to Waldenstrom's macroglobulinemia: a case report.

Authors:  Hui-Rong Xu; Jie Zhu; Xiao-Yan Xie; Jun Zhu; Fang Chen
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

3.  What the Silent Retina Tells You: Serous Retinal Detachment in Waldenström's Macroglobulinemia.

Authors:  Karima Amaador; Roselie Diederen; Jeroen Coumou; Josephine Vos
Journal:  Hemasphere       Date:  2021-01-20

4.  Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma.

Authors:  Natasha Ferreira Santos da Cruz; José Arthur Pinto Milhomens Filho; Desirée Mayara Nery Ferraro; Murilo Ubukata Polizelli; Nilva Simeren Bueno de Moraes Ambrogini
Journal:  Case Rep Ophthalmol       Date:  2021-07-01

5.  Localized retinal degeneration secondary to Waldenström's macroglobulinemia.

Authors:  Dhanashree Ratra; Vineet Ratra; Mansi Kishnani
Journal:  Oman J Ophthalmol       Date:  2017 Sep-Dec

6.  Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis.

Authors:  Michael J Schatz; Carl S Wilkins; Oscar Otero-Marquez; Toco Y P Chui; Richard B Rosen; Meenakashi Gupta
Journal:  Case Rep Ophthalmol Med       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.